Rolph Timothy's Form 4 filing
Akero Therapeutics, Inc. (AKRO) · filed May 8, 2025
- Accession no.
- 0000950170-25-067381
- Filed
- May 8, 2025
- Trade date
- May 6, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 1 derivative transaction. Open-market sales total $542.8K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Rolph TimothyCIK 0001779479 | Officer (Chief Scientific Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 6, 2025 | Common Stock | MOption exerciseAcquired | +12,500 | $21.10 | +$263,750 | 182,221 | Direct | |
| May 6, 2025 | Common Stock | SSaleDisposed | −3,550 | $42.26 | −$150,023 | 178,671 | Direct | |
| May 6, 2025 | Common Stock | SSaleDisposed | −8,650 | $43.87 | −$379,475.5 | 170,021 | Direct | |
| May 6, 2025 | Common Stock | SSaleDisposed | −300 | $44.50 | −$13,350 | 169,721 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 6, 2025 | Common Stock | MOption exerciseDisposed | −12,500 | $0.00 | $0 | 12,889 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.